|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenues | ||||
| Gross profit | ||||
| Selling and marketing expenses | ||||
| General and administrative expenses | ||||
| Research and development expenses | ||||
| Other income | ||||
| Expected credit losses | ||||
| Foreign currency exchange gains (losses), net | ||||
| Fair value measurement of financial instruments, net | ||||
| Other gains (losses), net | ||||
| Share listing expenses | ||||
| Restructuring costs | ||||
| Total operating expenses | ||||
| Operating income (loss) | ||||
| Interest income | ||||
| Interest income | ||||
| Finance costs | ||||
| Income tax (expense) benefit | ||||
| Total non-operating income (expenses) | ||||
| Profit (loss) before income tax | ||||
| Income tax (expense) benefit | ||||
| Profit (loss) | ||||
| Other comprehensive (loss) income | ||||
| Remeasurement of defined benefit plans | ||||
| Other comprehensive (loss) income for the year, net of tax | ||||
| Total comprehensive income (loss) for the year | ||||
| Exchange differences on translation of foreign operations | ||||
| Other comprehensive income (loss), net of tax | ||||
| Total comprehensive income (loss) | ||||
| Earnings (loss) per share | ||||
| Basic (in dollars per share) | ||||
| Diluted (in dollars per share) | ||||
| Weighted average number of shares used in computing earnings (loss) per share | ||||
| Basic (in shares) | ||||
| Diluted (in shares) |
Loading...
